FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

781529006: Hemostatic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3747469011 Hemostatic therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3747470012 Hemostatic therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3747471011 Haemostatic therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hemostatic therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing coagulation factor XI in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely coagulation factor XIII 1250 unit/1 vial powder for conventional release solution for injection Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only coagulation factor XI in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only coagulation factor IX in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing von Willebrand factor in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only thrombin in cutaneous dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only albutrepenonacog alfa in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only porcine factor VIII in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing thrombin in cutaneous dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing moroctocog alfa in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only nonacog alfa in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing recombinant coagulation factor IX in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only bovine thrombin in cutaneous dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Medicinal product acting as hemostatic (product) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing albutrepenonacog alfa in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing coagulation factor VIIa in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing efmoroctocog alfa in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only efmoroctocog alfa in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only moroctocog alfa in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing coagulation factor XIII in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only octocog alfa in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing octocog alfa in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing nonacog beta pegol in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only coagulation factor XIII in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing bovine thrombin in cutaneous dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing human fibrinogen in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing coagulation factor IX in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely coagulation factor XIII 250 unit/1 vial powder for conventional release solution for injection Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only human fibrinogen in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only coagulation factor Xa in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing nonacog alfa in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only coagulation factor VIIa in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing coagulation factor Xa in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only nonacog beta pegol in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing porcine factor VIII in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag 50 milligram/1 each conventional release oral tablet Plays role False Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing tranexamic acid in oral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing tranexamic acid in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing etamsylate in oral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing desmopressin in nasal dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely desmopressin acetate 10 microgram/1 actuation conventional release nasal spray (clinical drug) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only etamsylate in oral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing gelatin in cutaneous dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing aminocaproic acid in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only gelatin in cutaneous dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely desmopressin acetate 100 microgram/1 milliliter conventional release nasal solution Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing romiplostim in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing aminocaproic acid in oral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only desmopressin in nasal dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely aminocaproic acid 500 milligram/1 each conventional release oral tablet Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only recombinant antihemophilic factor pegylated liposome in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only desmopressin in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only aminocaproic acid in oral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only aminocaproic acid in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tranexamic acid 650 milligram/1 each conventional release oral tablet Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing oxidized cellulose in cutaneous dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only oxidized cellulose in cutaneous dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing eltrombopag in oral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing anti-inhibitor coagulant complex in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only anti-inhibitor coagulant complex in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing recombinant antihemophilic factor pegylated liposome in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag 25 milligram/1 each conventional release oral tablet Plays role False Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only romiplostim in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely etamsylate 500 milligram/1 each conventional release oral tablet Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing aprotinin in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing desmopressin in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag 75 milligram/1 each conventional release oral tablet Plays role False Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing emicizumab in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tranexamic acid 500 milligram/1 each conventional release oral tablet Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only aprotinin in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing carbazochrome in oral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only carbazochrome in oral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely romiplostim 250 microgram/1 vial powder for conventional release solution for injection Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only eltrombopag in oral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only tranexamic acid in oral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only tranexamic acid in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only emicizumab in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely desmopressin acetate 4 microgram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tranexamic acid 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing andexanet alfa in parenteral dose form (medicinal product form) Plays role False Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only andexanet alfa in parenteral dose form (medicinal product form) Plays role False Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely desmopressin acetate 150 microgram/1 actuation conventional release nasal spray (clinical drug) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely romiplostim 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely aminocaproic acid 250 milligram/1 milliliter conventional release oral solution (clinical drug) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely aprotinin 1.4 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only recombinant coagulation factor IX in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only von Willebrand factor in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Plays role False Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely nonacog alfa 1000 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Plays role False Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely nonacog alfa 500 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Plays role False Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely coagulation factor VIII 1000 unit and von Willebrand factor 2500 unit/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely coagulation factor VIII 500 unit and von Willebrand factor 1250 unit/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing coagulation factor VIII and von Willebrand factor in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing only coagulation factor VIII and von Willebrand factor in parenteral dose form (medicinal product form) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely octocog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Plays role False Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely octocog alfa 500 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Plays role False Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely desmopressin acetate 100 microgram/1 milliliter conventional release solution for nasal drops (clinical drug) Plays role False Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely desmopressin acetate 100 microgram/1 milliliter conventional release nasal drops (clinical drug) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely emicizumab 30 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely emicizumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag (as eltrombopag olamine) 25 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Hemostatic therapeutic role Inferred relationship Existential restriction modifier

Page 1 of 2 End

This concept is not in any reference sets

Back to Start